HCA Healthcare Inc (HCA) Shares Sold by Sheaff Brock Investment Advisors LLC
Sheaff Brock Investment Advisors LLC reduced its stake in HCA Healthcare Inc (NYSE:HCA) by 2.7% during the first quarter, according to its most recent filing with the SEC. The fund owned 3,635 shares of the company’s stock after selling 100 shares during the quarter. Sheaff Brock Investment Advisors LLC’s holdings in HCA Healthcare were worth $474,000 at the end of the most recent quarter.
Other large investors also recently modified their holdings of the company. Metropolis Capital Ltd boosted its holdings in shares of HCA Healthcare by 116.4% in the 1st quarter. Metropolis Capital Ltd now owns 238,510 shares of the company’s stock worth $31,097,000 after buying an additional 128,277 shares during the last quarter. Peak Asset Management LLC raised its stake in HCA Healthcare by 320.9% in the 4th quarter. Peak Asset Management LLC now owns 6,410 shares of the company’s stock valued at $798,000 after acquiring an additional 4,887 shares during the period. Cozad Asset Management Inc. raised its stake in HCA Healthcare by 18.8% in the 4th quarter. Cozad Asset Management Inc. now owns 21,368 shares of the company’s stock valued at $2,659,000 after acquiring an additional 3,375 shares during the period. State of Alaska Department of Revenue raised its stake in HCA Healthcare by 8.0% in the 4th quarter. State of Alaska Department of Revenue now owns 47,660 shares of the company’s stock valued at $5,928,000 after acquiring an additional 3,549 shares during the period. Finally, Pinnacle Financial Partners Inc. raised its stake in HCA Healthcare by 4.3% in the 4th quarter. Pinnacle Financial Partners Inc. now owns 96,954 shares of the company’s stock valued at $12,065,000 after acquiring an additional 4,023 shares during the period. 71.49% of the stock is currently owned by institutional investors.
Shares of HCA opened at $126.00 on Wednesday. HCA Healthcare Inc has a twelve month low of $93.03 and a twelve month high of $147.42. The stock has a market cap of $43.06 billion, a PE ratio of 12.90, a P/E/G ratio of 1.05 and a beta of 0.78.
The business also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Monday, June 3rd will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 1.27%. The ex-dividend date of this dividend is Friday, May 31st. HCA Healthcare’s dividend payout ratio is presently 16.38%.
A number of equities research analysts recently issued reports on the company. Barclays lowered their price objective on HCA Healthcare from $155.00 to $145.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 17th. Jefferies Financial Group set a $158.00 price objective on HCA Healthcare and gave the company a “buy” rating in a research note on Wednesday, April 17th. Raymond James upgraded HCA Healthcare from a “market perform” rating to an “outperform” rating and boosted their price objective for the company from $115.00 to $135.00 in a research note on Tuesday, April 23rd. Zacks Investment Research cut HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday, January 2nd. Finally, Oppenheimer boosted their price objective on HCA Healthcare from $142.00 to $150.00 and gave the company an “outperform” rating in a research note on Wednesday, January 30th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and eighteen have issued a buy rating to the stock. HCA Healthcare has a consensus rating of “Buy” and an average target price of $147.59.
In related news, SVP J William Morrow sold 263 shares of the company’s stock in a transaction that occurred on Thursday, February 7th. The shares were sold at an average price of $140.60, for a total value of $36,977.80. Following the transaction, the senior vice president now directly owns 5,922 shares in the company, valued at $832,633.20. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Bill B. Rutherford sold 37,500 shares of the company’s stock in a transaction that occurred on Tuesday, February 12th. The stock was sold at an average price of $139.65, for a total transaction of $5,236,875.00. Following the completion of the transaction, the chief financial officer now owns 58,972 shares in the company, valued at $8,235,439.80. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 78,476 shares of company stock worth $10,940,008. Company insiders own 2.70% of the company’s stock.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Featured Story: Cost of Capital
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.